Clinical Trials Browser

Phase 1/2 × Prostatic Neoplasms × ipatasertib × Clear all

NCT04737109 2023-11-13

ADDItion

Phase 1/2 Terminated

6 enrolled 9 charts

Prostatic Neoplasms

NCT01485861 2023-09-14

Study of Ipatasertib or Apitolisib With Abiraterone Acetate Versus Abiraterone Acetate in Participants With Castration-Resistant Prostate Cancer Previously Treated With Docetaxel Chemotherapy

Phase 1/2 Completed

298 enrolled 58 charts

Prostatic Neoplasms